Consultant gynaecological oncologist, Dr Esther Moss, said the test could not only detect cancer recurrence more quickly but also avoid the need for confirmatory invasive biopsies and was undergoing further validation before being used in everyday clinical practice.
Trending
- Work begins on Sir Bobby Robson cancer centre
- MRD End Point Brings “Positive Change” to Multiple Myeloma Research
- Translating Innovation Into Practice: Highlights From the 43rd Annual Miami Breast Cancer Conference
- Microplastics and nanoplastics in brain tumours and the healthy human brain
- Data science: has AI solved drug discovery? – Cancer Research UK
- Teen plans 'best send off' for terminally ill dad
- Cancer podcast hosts urge people to get support
- Heterogeneity and plasticity of cancer-associated fibroblasts

